SCHEMBL6268045

SCHEMBL6268045

O=C(N[C@H](Cc1ccc2c(c1)CCCC2)C(=O)N1CCC(N2CCN(Cc3ccccc3)CC2)CC1)ON1CCC(n2nc(-c3ccccc3)[nH]c2=O)CC1

nearest known ligand 0.41

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CALCRL Q16602 18/20 0.41
CYP3A4 P08684 10/20 0.41
RAMP1 O60894 2/20 0.38
MMP1 P03956 1/20 0.37
MMP3 P08254 1/20 0.37
CALCA P06881 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6265245 0.91 CALCRL (0.41) CALCRLCYP3A4RAMP1CALCA
SCHEMBL6263478 0.91 CALCRL (0.43) CALCRLCYP3A4RAMP1
SCHEMBL3278367 0.91 CALCRL (0.50) CALCRLCYP3A4RAMP1CALCA
SCHEMBL13303434 0.89 CALCRL (0.49) CALCRLCYP3A4RAMP1CALCA
SCHEMBL3277723 0.83 CALCRL (0.51) CALCRLCYP3A4CALCA
SCHEMBL6262515 0.82 CALCRL (0.54) CALCRLCYP3A4RAMP1
SCHEMBL3277767 0.82 CALCRL (0.52) CALCRLCYP3A4RAMP1CALCA
SCHEMBL6227702 0.82 CALCRL (0.40) CALCRLCYP3A4RAMP1CALCA
SCHEMBL6267533 0.82 CALCRL (0.45) CALCRLCYP3A4CALCA
SCHEMBL3278176 0.78 CALCRL (0.49) CALCRLCYP3A4RAMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1558601-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP claimed
WO-2004037811-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO claimed
EP-1558601-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2005-08-03 EP disclosed
WO-2004037811-A1 SELECTED CGRP ANTAGONISTS, METHOD FOR PRODUCTION AND USE THEREOF AS MEDICAMENT BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2004-05-06 WO disclosed